vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Consolidated Water Co. Ltd. (CWCO). Click either name above to swap in a different company.

AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $29.6M, roughly 1.5× Consolidated Water Co. Ltd.). Consolidated Water Co. Ltd. runs the higher net margin — 10.3% vs -19.9%, a 30.2% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 4.4%). Consolidated Water Co. Ltd. produced more free cash flow last quarter ($3.4M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -13.6%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Coca-Cola Consolidated, Inc., headquartered in Charlotte, North Carolina, is the largest independent Coca-Cola bottler in the United States.

ABCL vs CWCO — Head-to-Head

Bigger by revenue
ABCL
ABCL
1.5× larger
ABCL
$44.9M
$29.6M
CWCO
Growing faster (revenue YoY)
ABCL
ABCL
+784.0% gap
ABCL
788.4%
4.4%
CWCO
Higher net margin
CWCO
CWCO
30.2% more per $
CWCO
10.3%
-19.9%
ABCL
More free cash flow
CWCO
CWCO
$48.0M more FCF
CWCO
$3.4M
$-44.6M
ABCL
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
-13.6%
CWCO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABCL
ABCL
CWCO
CWCO
Revenue
$44.9M
$29.6M
Net Profit
$-8.9M
$3.0M
Gross Margin
34.7%
Operating Margin
-63.7%
9.1%
Net Margin
-19.9%
10.3%
Revenue YoY
788.4%
4.4%
Net Profit YoY
73.9%
91.5%
EPS (diluted)
$-0.03
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
CWCO
CWCO
Q4 25
$44.9M
$29.6M
Q3 25
$9.0M
$35.1M
Q2 25
$17.1M
$33.6M
Q1 25
$4.2M
$33.7M
Q4 24
$5.0M
$28.4M
Q3 24
$6.5M
$33.4M
Q2 24
$7.3M
$32.5M
Q1 24
$10.0M
$39.7M
Net Profit
ABCL
ABCL
CWCO
CWCO
Q4 25
$-8.9M
$3.0M
Q3 25
$-57.1M
$5.5M
Q2 25
$-34.7M
$5.1M
Q1 25
$-45.6M
$4.8M
Q4 24
$1.6M
Q3 24
$-51.1M
$4.5M
Q2 24
$-36.9M
$15.9M
Q1 24
$-40.6M
$6.5M
Gross Margin
ABCL
ABCL
CWCO
CWCO
Q4 25
34.7%
Q3 25
36.9%
Q2 25
38.2%
Q1 25
36.5%
Q4 24
29.9%
Q3 24
34.8%
Q2 24
35.8%
Q1 24
35.0%
Operating Margin
ABCL
ABCL
CWCO
CWCO
Q4 25
-63.7%
9.1%
Q3 25
-851.8%
16.4%
Q2 25
-290.2%
15.7%
Q1 25
-1479.6%
13.7%
Q4 24
3.8%
Q3 24
-1439.4%
14.6%
Q2 24
-1276.2%
15.4%
Q1 24
-551.5%
18.4%
Net Margin
ABCL
ABCL
CWCO
CWCO
Q4 25
-19.9%
10.3%
Q3 25
-637.8%
15.8%
Q2 25
-203.3%
15.2%
Q1 25
-1077.2%
14.2%
Q4 24
5.6%
Q3 24
-785.4%
13.3%
Q2 24
-504.3%
48.8%
Q1 24
-408.0%
16.3%
EPS (diluted)
ABCL
ABCL
CWCO
CWCO
Q4 25
$-0.03
$0.18
Q3 25
$-0.19
$0.34
Q2 25
$-0.12
$0.32
Q1 25
$-0.15
$0.30
Q4 24
$0.10
Q3 24
$-0.17
$0.28
Q2 24
$-0.13
$0.99
Q1 24
$-0.14
$0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
CWCO
CWCO
Cash + ST InvestmentsLiquidity on hand
$128.5M
$123.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$966.9M
$221.7M
Total Assets
$1.4B
$257.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
CWCO
CWCO
Q4 25
$128.5M
$123.8M
Q3 25
$83.2M
$123.6M
Q2 25
$92.4M
$112.2M
Q1 25
$159.3M
$107.9M
Q4 24
$156.3M
$99.4M
Q3 24
$126.6M
$104.9M
Q2 24
$148.3M
$96.7M
Q1 24
$123.6M
$46.2M
Stockholders' Equity
ABCL
ABCL
CWCO
CWCO
Q4 25
$966.9M
$221.7M
Q3 25
$964.0M
$220.4M
Q2 25
$1.0B
$216.6M
Q1 25
$1.0B
$213.3M
Q4 24
$1.1B
$210.0M
Q3 24
$1.1B
$209.8M
Q2 24
$1.1B
$206.7M
Q1 24
$1.1B
$192.1M
Total Assets
ABCL
ABCL
CWCO
CWCO
Q4 25
$1.4B
$257.6M
Q3 25
$1.4B
$257.2M
Q2 25
$1.4B
$257.5M
Q1 25
$1.3B
$250.4M
Q4 24
$1.4B
$243.3M
Q3 24
$1.4B
$238.4M
Q2 24
$1.4B
$235.2M
Q1 24
$1.5B
$223.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
CWCO
CWCO
Operating Cash FlowLast quarter
$-34.7M
$5.8M
Free Cash FlowOCF − Capex
$-44.6M
$3.4M
FCF MarginFCF / Revenue
-99.4%
11.4%
Capex IntensityCapex / Revenue
21.9%
8.1%
Cash ConversionOCF / Net Profit
1.90×
TTM Free Cash FlowTrailing 4 quarters
$-174.1M
$33.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
CWCO
CWCO
Q4 25
$-34.7M
$5.8M
Q3 25
$-52.6M
$15.4M
Q2 25
$-32.4M
$8.8M
Q1 25
$-11.6M
$11.8M
Q4 24
$-108.6M
$-742.0K
Q3 24
$-28.9M
$10.4M
Q2 24
$-30.0M
$21.0M
Q1 24
$-41.7M
$6.0M
Free Cash Flow
ABCL
ABCL
CWCO
CWCO
Q4 25
$-44.6M
$3.4M
Q3 25
$-61.5M
$13.5M
Q2 25
$-45.8M
$6.1M
Q1 25
$-22.2M
$10.2M
Q4 24
$-187.0M
$-3.7M
Q3 24
$-47.4M
$8.3M
Q2 24
$-50.1M
$19.8M
Q1 24
$-65.8M
$5.4M
FCF Margin
ABCL
ABCL
CWCO
CWCO
Q4 25
-99.4%
11.4%
Q3 25
-687.0%
38.4%
Q2 25
-267.9%
18.3%
Q1 25
-524.0%
30.1%
Q4 24
-3702.8%
-13.0%
Q3 24
-728.4%
24.9%
Q2 24
-683.8%
60.8%
Q1 24
-661.5%
13.7%
Capex Intensity
ABCL
ABCL
CWCO
CWCO
Q4 25
21.9%
8.1%
Q3 25
99.7%
5.5%
Q2 25
78.2%
7.8%
Q1 25
251.1%
4.7%
Q4 24
1552.7%
10.4%
Q3 24
284.6%
6.1%
Q2 24
274.6%
3.7%
Q1 24
242.5%
1.3%
Cash Conversion
ABCL
ABCL
CWCO
CWCO
Q4 25
1.90×
Q3 25
2.79×
Q2 25
1.72×
Q1 25
2.45×
Q4 24
-0.47×
Q3 24
2.32×
Q2 24
1.32×
Q1 24
0.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABCL
ABCL

Segment breakdown not available.

CWCO
CWCO

Services Revenues$10.5M35%
Transferred At Point In Time$8.5M29%
Operations And Maintenance$8.4M28%
Transferred Over Time$1.9M7%

Related Comparisons